MedPath

Validation research study on migraine (Validation research study using questionnaire surveys and health insurance association medical claim data)

Not Applicable
Conditions
Migraine
Registration Number
JPRN-UMIN000048684
Lead Sponsor
Otsuka Pharmaceuticals Co., Ltd
Brief Summary

sing a questionnaire linked claim data,we examined the most appropriate receipt conditions for migraine subjects identified by the ICHD-3 and 2 screeners.The most common combination of the PPV was "at least two migraine diagnoses and at least one prescription of migraine prophylaxis or triptans in the same month as the migraine diagnosis", suggesting that these were appropriate conditions for the migraine patients identified in the ICHD-3 condition

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
21480
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PPV (PPV:Positive Predictive Value)
Secondary Outcome Measures
NameTimeMethod
Sensitivity Specificity NPV (NPV: Negative Predictive Value)
© Copyright 2025. All Rights Reserved by MedPath